Are Recombinant Monoclonal Antibodies the Ultimate Solution for Batch-to-Batch Consistency in Research?
Recombinant monoclonal antibodies bring genetic precision, engineering flexibility, and cutting-edge quality control to the lab—dramatically reducing lot-to-lot differences that undermine reproducibility. In this deep dive, we unpack their advantages, explore remaining challenges around glycosylation and cost, and look ahead to AI-driven design and hybrid antibody strategies.